Developing a standard approach to immune checkpoint inhibitor toxicity management in Ontario.

被引:0
作者
Crespo, Andrea
Abella, Lourdes
Baetz, Tara D.
Gallo-Hershberg, Daniela
Lakhani, Nita
Leighl, Natasha B.
Pasetka, Mark
Seymour, Lesley
Vu, Kathy
Forbes, Leta Marie
机构
[1] Canc Care Ontario, Toronto, ON, Canada
[2] Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
关键词
D O I
10.1200/JCO.2018.36.30_suppl.255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
255
引用
收藏
页数:2
相关论文
共 50 条
[21]   At the Heart of Immune checkpoint Inhibitor-Induced Immune Toxicity [J].
Young, Arabella ;
Bluestone, Jeffrey A. .
CANCER DISCOVERY, 2021, 11 (03) :537-539
[22]   Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series [J].
Harvey, Catriona ;
Nahar, Kazi J. ;
Mckeown, Janet ;
Lo, Serigne N. ;
Farag, Sheima ;
Yousaf, Nadia ;
Young, Kate ;
Tas, Liselotte ;
Meerveld-Eggink, Aafke ;
Blank, Christian ;
Thomas, Austin ;
Mcquade, Jennifer ;
Schilling, Bastian ;
Johnson, Douglas B. ;
Huertas, Roberto Martin ;
Arance, Ana ;
Lee, Joanna ;
Zimmer, Lisa ;
Long, Georgina, V ;
Carlino, Matteo S. ;
Wang, Yinghong ;
Menzies, Alexander Maxwell .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
[23]   A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy [J].
Kottschade, Lisa ;
Brys, Adam ;
Peikert, Tobias ;
Ryder, Mabel ;
Raffals, Laura ;
Brewer, Jerry ;
Mosca, Paul ;
Markovic, Svetomir .
MELANOMA RESEARCH, 2016, 26 (05) :469-480
[24]   Management of Immune Checkpoint Inhibitor Mediated Myocarditis [J].
Mudra, Sarah ;
Culver, Austin ;
Kumar, Ashwin ;
Yesilyaprak, Abdullah ;
Agrawal, Ankit ;
Dey, Amit K. ;
Rizk, Alexander ;
Li, Jason ;
Johnson, Adam ;
McGowan, Kevin ;
Majid, Muhammad ;
Njus, Meredith ;
Lawrence, Luke ;
Klein, Allan L. .
CIRCULATION, 2023, 148
[25]   Immunity and immune toxicity: clinical management of immune checkpoint inhibition [J].
Keilholz, U. .
RADIOTHERAPY AND ONCOLOGY, 2017, 122 :21-21
[26]   Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review [J].
Sise, Meghan E. ;
Seethapathy, Harish ;
Reynolds, Kerry L. .
ONCOLOGIST, 2019, 24 (06) :735-742
[27]   Management of infliximab-refractory immune checkpoint inhibitor gastrointestinal toxicity: A multicenter case series [J].
Harvey, Catriona ;
Nahar, Kazi Jannatun ;
Lo, Serigne N. ;
Ahmed, Tasnia ;
Farag, Sheima ;
Yousaf, Nadia ;
Young, Kate ;
Tas, Liselotte ;
Meerveld-Eggink, Aafke ;
Blank, Christian U. ;
Thomas, Austin ;
McQuade, Jennifer Leigh ;
Schilling, Bastian ;
Johnson, Douglas Buckner ;
Huertas, Roberto Martin ;
Arance, Ana Maria ;
Lee, Joanna ;
Zimmer, Lisa ;
Long, Georgina V. ;
Menzies, Alexander M. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[28]   GRAVE CONSEQUENCES OF IMMUNE CHECKPOINT INHIBITOR TOXICITY BEYOND MYOCARDITIS [J].
Trivedi, Rishi ;
Tacon, Phillip ;
Aiken, Achilles V. ;
Chyu, Kuang-Yuh ;
Ebinger, Joseph .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) :3470-3470
[29]   Immune Checkpoint Inhibitor Toxicity Review for the Palliative Care Clinician [J].
Hansen, Eric D. ;
Wang, Xiao ;
Case, Amy A. ;
Puzanov, Igor ;
Smith, Tom .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2018, 56 (03) :460-472
[30]   Immune checkpoint inhibitor and encephalic radiotherapy: Toxicity and Adverse events [J].
Matteucci, P. ;
Santo, B. ;
Ippolito, E. ;
Zuccoli, P. ;
Petrianni, G. M. ;
Trecca, P. ;
Gentile, S. ;
Miele, M. ;
Palizzi, S. ;
Trodella, L. ;
D'Angelillo, R. M. ;
Ramella, S. .
RADIOTHERAPY AND ONCOLOGY, 2019, 133 :S678-S678